Acro Biomedical (ACBM) Total Liabilities (2015 - 2026)

Acro Biomedical has reported Total Liabilities for 12 years, with the latest figure at $448437.0 in Q2 2026.

• On a quarterly basis, Total Liabilities rose 20.94% year-over-year to $448437.0 in Q2 2026; TTM through Jun 2026 was $448437.0, a 20.94% increase from a year earlier, with the FY2025 full-year figure at -$100.0 million, down 30681.78% from the prior year.
• Total Liabilities was $448437.0 for Q2 2026 at Acro Biomedical, up from $401062.0 in the prior quarter.
• The five-year high for Total Liabilities was $448437.0 in Q2 2026, with the low at $85375.0 in Q1 2022.
• Average Total Liabilities over 5 years is $284075.7, with a median of $318104.0 recorded in 2024.
• The sharpest annual moves came in 2022 and 2023: Total Liabilities sank 72.46% in 2022, then soared 188.18% in 2023.
• Over 5 years, Total Liabilities stood at $201116.0 in 2022, then jumped by 56.86% to $315473.0 in 2023, then climbed by 3.64% to $326946.0 in 2024, then grew by 22.67% to $401062.0 in 2025, then rose by 11.81% to $448437.0 in 2026.
• The last three Total Liabilities figures came in at $448437.0 (Q2 2026), $401062.0 (Q4 2025), and $436942.0 (Q3 2025), per Business Quant data.